期刊文献+

肾盂输尿管癌术后膀胱灌注化疗对复发膀胱癌的影响 被引量:6

The influence of irrigation of bladder to the recurrence of bladder tumors after surgery of upper urinary tract tumors
原文传递
导出
摘要 目的探讨肾盂输尿管癌术后膀胱灌注化疗对膀胱复发癌的影响。方法对96例获随访的原发性肾盂输尿管癌患者的临床资料进行回顾性研究总结。结果行肾盂输尿管膀胱部分切除术术后未进行膀胱灌注化疗的患者膀胱癌复发率为34.4%(11/32),术后行膀胱灌注化疗者膀胱癌复发率为18.8%(12/64),差异有显著性意义(P〈0.05)。术后24小时内行膀胱灌注化疗者膀胱肿瘤术后复发率17.2%(5/29)小于术后2周行膀胱灌注化疗者20%(7/35),两者相比较,差异无显著性意义(P〉0.05)。术中先行输尿管末端结扎者术后膀胱癌复发率较未采取结扎措施者低,但两者相比未见统计学意义(p〉0.05)。结论肾盂输尿管癌行肾输尿管膀胱部分切除术后预防性膀胱灌注化疗可有效降低复发性膀胱癌的发生率。术中游离肾输尿管前行输尿管末端结扎并同时行预防性膀胱灌注化疗对预防肾盂输尿管癌术后再发膀胱癌可能有效。 Objectives To investigate the influence of irrigation of bladder to the recurrence of bladder tumors after surgery of upper urinary tract transitional cell carcinoma of the upper urinary tract. Methods The 96 patients who underwent total nephroureterectomy for clinically localized transitional cell carcinoma of the upper urinary trace, All of them were followed up and their data were retrospectively analyzed. Results After nephroureterectony and resection of partial bladder wall, the bladder transitional cell carcinoma ( TCC ) recurrence rate was 34.4% (11/32) in pntient who bad rejected adoption intravesical chemotherapy , being obviously higher than patient who adoption intravesical chemotherapy 18.8% (12/64, p 〈 0.05 ). The recurrence rates in those who had prophylactic intravesical instillation 24 hours after surgery, and in those who had the instillation 2 weeks after surgery were 17. 2% (5/29) and 20% (7/35) , respectively. There was no significant difference between them ( p 〉 0.05 ). The bladder TCC recurrence rates in patient whose ureter had been ligated before the kidney was dissociated lower than whose ureter had not been ligated. Although the difference was not statistically significant the result demonstrated a strong trend that this surgery method may contribute to prevent the bladder TCC recurrence. Conclusions The prophylactic intravesical chemotherapy is a useful approach for reducing the recurrence of bladder TCC after surgery of upper urinary tract TCC. A possible reduction of bladder TCC-risk by intraoperative ureteric ligation and/or peri - operative topical intravesical chemotherapy instillation are justified.
出处 《国际泌尿系统杂志》 2009年第3期300-303,共4页 International Journal of Urology and Nephrology
关键词 肾肿瘤 输尿管肿瘤 膀胱肿瘤 Kidney Neoplasms Ureteral Ueopasms Bladder Neoplasms
  • 相关文献

参考文献10

  • 1Kauffman EC, Raman JD Bladder cancer following upper tract urothelial carcinoma. Expert Rev Anticancer Ther. 2008,8 (1) :75 -85.
  • 2Kang CH, Yu U, Hsieh HH, et al. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract. Cancer,2003,98 : 1620 - 1626.
  • 3Hafner C, Knuechel R, Stoehr R , et al . Clonatity of multifoeal urothelial carcinomas 10 years of molecular genetic studies. Int J Cancer,2002,101 : 1 - 6.
  • 4Takahashi T, Habuchi T. Clonal and chronological cancers of the bladder and upper urinary tract Cancer Res, 1988,58:5835 - 5841.
  • 5Akdogan B, Dogan HS, Eskicorapci SY et al. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006,176(1) :48 -52.
  • 6Sakamoto N, Naito S, Kumazawa J, et al. Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study. Int J Urol. 2001 May;8 (5) :212 -216.
  • 7Bouflloux C, Kurth KH, Bono A, et al. Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: results of 2 Wuropean Organization for Research and Treatment of Cancer randomized trials with mitomycin C and doxombicin comaring early versus delayed instillations and short - term versus long - term treatment J Urol, 1995,153:934 - 941.
  • 8Matsui Y, Utsunomiya N, Ichioka K, et al. Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. Urology,2005,65 ( 2 ) :279 - 283.
  • 9Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence in transitional cell carcinoma of the upper urinary tract : a 30 - year experience in 252 patients. Urology, 1998,52 (4) : 594 - 601.
  • 10Hong B, Park S, Hong JH, et al. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Urology,2005,65 (4) :692 - 696.

同被引文献35

  • 1李作为,邱建新.浅表性膀胱癌灌注治疗进展[J].世界临床药物,2009,30(11):650-656. 被引量:3
  • 2张争,潘柏年.原发性输尿管癌影响预后因素分析[J].中华泌尿外科杂志,2004,25(12):838-840. 被引量:19
  • 3潘柏年,张争,刘玉立,郭应禄.174例原发性输尿管癌的临床分析[J].中华外科杂志,2004,42(23):1447-1449. 被引量:59
  • 4关有彦,李宁忱,周利群,何志嵩,李鸣,那彦群.输尿管癌预后相关因素的临床研究[J].中华外科杂志,2007,45(18):1260-1263. 被引量:5
  • 5Kirkali Z,Tuzel E.Transitional cell carcinoma of the ureter and renal pelvis[J].Crit Rev Oncol Hematol,2003,47(2):155-169.
  • 6Soderdahl DW,Fabrizio MD,Rahman NU,et al.Endoscopic treatment of upper tract transitional cell carcinoma[J].Urol Oncol,2005,23 (2):114-122.
  • 7Colin P,Ouzzane A,Pignot G,et al.Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract:results from a large French multicentre study[J].BJU Int,2012,110(8):1134-1141.
  • 8Arthur IS,Thomas WJ,Robert CF.Urothelial tumors of the upper urinary tract and ureter//Alan JW,Louis RK,Andrew CN,et al.Campbell-Waish Urology[M].10th ed.Philadelphia:Saunders WBCo,2012:1516-1553.
  • 9Bagrodia A,Kuehhas FE,Gayed BA,et al.Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma[J].Urology,2013,81 (5):972-977.
  • 10van der Poel HG,Antomini N,van Tinteren H,et al.Upper urinary tract cancer:location is correlated with prognosis[J].Eur Urol,2005,48(3):438-444.

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部